Group 1 - The core point of the news is the resignation of Huang Linxiang as the employee representative director and CFO of Le Xin Medical due to personal reasons, and the appointment of Wu Rong as the new CFO [1] - Le Xin Medical's revenue composition for the first half of 2025 is as follows: home medical products account for 66.29%, electronic health scales account for 24.17%, other products account for 7.55%, and wearable sports wristbands account for 1.99% [1] - As of the report date, Le Xin Medical has a market capitalization of 3.2 billion yuan [1] Group 2 - Related news includes the resignation of Yi Bingmin from Gao Le Co. as CFO and Vice General Manager [2] - Zhao Bin's resignation as Vice President and CFO of Yingxin Development is also noted [2] - Chen Feng Technology has appointed Dong Jianzao as the new CFO [2]

Company Changes - Huang Linxiang resigned from her positions as employee representative director and CFO due to personal reasons, and will no longer hold any positions in the company or its subsidiaries [1] - Wu Rong has been appointed as the new CFO after being nominated by the general manager and approved by the board's nomination and audit committees [1] Financial Performance - For the first half of 2025, the revenue composition of the company is as follows: home medical products accounted for 66.29%, electronic health scales for 24.17%, others for 7.55%, and wearable fitness bands for 1.99% [1] - The current market capitalization of the company is 3.2 billion yuan [1]

Group 1 - The core point of the news is that 乐心医疗 (Lixun Medical) announced a board meeting to discuss the authorization of a stock option incentive plan for 2025 [1] - For the first half of 2025, the revenue composition of 乐心医疗 is as follows: home medical products account for 66.29%, electronic health scales for 24.17%, others for 7.55%, and wearable fitness bands for 1.99% [1] - As of the report, 乐心医疗 has a market capitalization of 3.2 billion yuan [1]

Group 1 - The core point of the article is that 乐心医疗 (Lixun Medical) held its fifth board meeting on August 29, 2025, to discuss adjustments to its fundraising investment projects and extensions [1] - For the first half of 2025, the revenue composition of 乐心医疗 is as follows: home medical products accounted for 66.29%, electronic health scales for 24.17%, others for 7.55%, and wearable fitness bands for 1.99% [1] - As of the report date, 乐心医疗 has a market capitalization of 3.3 billion yuan [1]

每经AI快讯，乐心医疗（SZ 300562，收盘价：16.96元）8月15日晚间发布公告称，公司第五届第三次 董事会会议于2025年8月14日在公司会议室以现场结合通讯方式召开。会议审议了《关于<2025年半年 度报告全文>及摘要的议案》等文件。 （记者 张喜威） 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每日经济新闻 2025年1至6月份，乐心医疗的营业收入构成为：家用医疗产品占比66.29%，电子健康秤占比24.17%， 其他占比7.55%，可穿戴运动手环占比1.99%。 截至发稿，乐心医疗市值为37亿元。 每经头条（nbdtoutiao）——连胜之后匹配"猪队友"，连败之后则"摆烂"都能赢？中国游戏算法第一案 开庭，资深玩家与《王者荣耀》对簿公堂 ...